Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 263786, 12 pages
http://dx.doi.org/10.1155/2014/263786
Research Article

Niacin Inhibits Vascular Inflammation via Downregulating Nuclear Transcription Factor-κB Signaling Pathway

1Key Laboratory of Atherosclerosis in Universities of Shandong and Institute of Atherosclerosis, Taishan Medical University, Shandong 271000, China
2College of Basic Medical Sciences, Taishan Medical University, Shandong 271000, China
3Shandong Agricultural University, Shandong 271000, China
4Department of Geriatrics, PLA Navy General Hospital, Beijing 100048, China

Received 9 January 2014; Revised 1 April 2014; Accepted 16 April 2014; Published 27 May 2014

Academic Editor: Clara Di Filippo

Copyright © 2014 Yanhong Si et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Altschul, A. Hoffer, and J. D. Stephen, “Influence of nicotinic acid on serum cholesterol in man,” Archives of Biochemistry and Biophysics, vol. 54, no. 2, pp. 558–559, 1955. View at Google Scholar · View at Scopus
  2. C. D. Meyers, V. S. Kamanna, and M. L. Kashyap, “Niacin therapy in atherosclerosis,” Current Opinion in Lipidology, vol. 15, no. 6, pp. 659–665, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Carlson, “Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review,” Journal of Internal Medicine, vol. 258, no. 2, pp. 94–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Ganji, S. Qin, L. Zhang, V. S. Kamanna, and M. L. Kashyap, “Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells,” Atherosclerosis, vol. 202, no. 1, pp. 68–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. T. Kuvin, D. M. Dave, K. A. Sliney et al., “Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease,” American Journal of Cardiology, vol. 98, no. 6, pp. 743–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Yang, P. Guo, X. Song, F. Liu, and N. Gao, “Hyperlipidemic guinea pig model: mechanisms of triglyceride metabolism disorder and comparison to rat,” Biological and Pharmaceutical Bulletin, vol. 34, no. 7, pp. 1046–1051, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Li, Y. Liu, H. Zhang, L. Ren, Q. Li, and N. Li, “Animal models for the atherosclerosis research: a review,” Protein and Cell, vol. 2, no. 3, pp. 189–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. O. Leite, U. Vaishnav, M. Puglisi, H. Fraser, J. Trias, and M. L. Fernandez, “A-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs,” BMC Cardiovascular Disorders, vol. 9, article 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Auwerx, “The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation,” Experientia, vol. 47, no. 1, pp. 22–31, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Chapman, G. L. Mills, and J. H. Ledford, “The distribution and partial characterization of the serum apolipoproteins in the guinea pig,” Biochemical Journal, vol. 149, no. 2, pp. 423–436, 1975. View at Google Scholar · View at Scopus
  11. X. C. Jiang, C. Bruce, J. Mar et al., “Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels,” Journal of Clinical Investigation, vol. 103, no. 6, pp. 907–914, 1999. View at Google Scholar · View at Scopus
  12. T. Collins and M. I. Cybulsky, “NF-κB: pivotal mediator or innocent bystander in atherogenesis?” Journal of Clinical Investigation, vol. 107, no. 3, pp. 255–264, 2001. View at Google Scholar · View at Scopus
  13. Y. Tsubosaka, T. Murata, K. Yamada, D. Uemura, M. Hori, and H. Ozaki, “Halichlorine reduces monocyte adhesion to endothelium through the suppression of nuclear factor-κB activation,” Journal of Pharmacological Sciences, vol. 113, no. 3, pp. 208–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Tsutsui, “Mitochondrial oxidative stress and heart failure,” Internal Medicine, vol. 45, no. 13, pp. 809–813, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Seddon, Y. H. Looi, and A. M. Shah, “Oxidative stress and redox signalling in cardiac hypertrophy and heart failure,” Heart, vol. 93, no. 8, pp. 903–907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Wongchana and T. Palaga, “Direct regulation of interleukin-6 expression by Notch signaling in macrophages,” Cellular and Molecular Immunology, vol. 9, no. 2, pp. 155–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Chen, H. Zhao, X. Ma et al., “The effects of jiang-zhi-ning and its main components on cholesterol metabolism,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 928234, 10 pages, 2012. View at Publisher · View at Google Scholar
  18. G. Francisco, C. Hernández, and R. Simó, “Serum markers of vascular inflammation in dyslipemia,” Clinica Chimica Acta, vol. 369, no. 2, pp. 1–16, 2006. View at Publisher · View at Google Scholar
  19. J. Andersson, P. Libby, and G. K. Hansson, “Adaptive immunity and atherosclerosis,” Clinical Immunology, vol. 134, no. 1, pp. 33–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. W. J. Oh, U. Jung, H. S. Eom, H. J. Shin, and H. R. Park, “Inhibition of lipopolysaccharide-induced proinflammatory responses by Buddleja officinalis extract in BV-2 microglial cells via negative regulation of NF-kB and ERK1/2 signaling,” Molecules, vol. 18, no. 8, pp. 9195–9206, 2013. View at Publisher · View at Google Scholar
  21. T. M. Wang, C. J. Chen, T. S. Lee et al., “Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells,” Journal of Nutritional Biochemistry, vol. 22, no. 2, pp. 187–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Islam, H. Yoshida, N. Matsuki et al., “Antioxidant, free radical-scavenging, and NF-κB-inhibitory activities of phytosteryl ferulates: structure-activity studies,” Journal of Pharmacological Sciences, vol. 111, no. 4, pp. 328–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P. M. Ridker, M. J. Stampfer, and N. Rifai, “Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease,” Journal of the American Medical Association, vol. 285, no. 19, pp. 2481–2485, 2001. View at Google Scholar · View at Scopus
  24. M. Thoenes, A. Oguchi, S. Nagamia et al., “The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome,” International Journal of Clinical Practice, vol. 61, no. 11, pp. 1942–1948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. N. R. Madamanchi, A. Vendrov, and M. S. Runge, “Oxidative stress and vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 29–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Matsuura, F. Atzeni, P. Sarzi-Puttini, M. Turiel, L. R. Lopez, and M. T. Nurmohamed, “Is atherosclerosis an autoimmune disease?” BMC Medicine, vol. 12, no. 1, article 47, 2014. View at Publisher · View at Google Scholar
  27. A. Pirillo, G. D. Norata, and A. L. Catapano, “LOX-1, OxLDL, and atherosclerosis,” Mediators of Inflammation, vol. 2013, Article ID 152786, 12 pages, 2013. View at Publisher · View at Google Scholar
  28. C. L. Wang, M. Meng, S. B. Liu, L. R. Wang, L. H. Hou, and X. H. Cao, “chemically sulfated polysaccharide from Grifola frondos induces HepG2 cell apoptosis by notch1-NF-κB pathway,” Carbohydrate Polymers, vol. 95, no. 1, pp. 282–287, 2013. View at Publisher · View at Google Scholar
  29. W. Wongchana and T. Palaga, “Direct regulation of interleukin-6 expression by Notch signaling in macrophages,” Cellular and Molecular Immunology, vol. 9, no. 2, pp. 155–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Choy, D. J. Granville, D. W. C. Hunt, and B. M. McManus, “Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 9, pp. 1673–1690, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Cuchel and D. J. Rader, “Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?” Circulation, vol. 113, no. 21, pp. 2548–2555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Yazdanyar, C. Yeang, and X. C. Jiang, “Role of phospholipid transfer protein in high-density lipoprotein-mediated reverse cholesterol transport,” Current Atherosclerosis Reports, vol. 13, no. 3, pp. 242–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Wang and D. J. Rader, “Molecular regulation of macrophage reverse cholesterol transport,” Current Opinion in Cardiology, vol. 22, no. 4, pp. 368–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. J. Yang, J. M. Choi, L. Kim et al., “Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes,” Journal of Nutritional Biochemistry, vol. 25, no. 1, pp. 66–72, 2014. View at Publisher · View at Google Scholar
  35. L. A. Carlson, L. Orö, and J. Ostman, “Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia,” Acta Medica Scandinavica, vol. 183, no. 5, pp. 457–465, 1968. View at Google Scholar · View at Scopus
  36. R. H. Stern, J. D. Spence, D. J. Freeman, and A. Parbtani, “Tolerance to nicotinic acid flushing,” Clinical Pharmacology and Therapeutics, vol. 50, no. 1, pp. 66–70, 1991. View at Google Scholar · View at Scopus
  37. S. M. Grundy, J. I. Cleeman, C. N. Bairey Merz et al., “Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines,” Circulation, vol. 110, no. 2, pp. 227–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. S. Brown and J. L. Goldstein, “Lowering plasma cholesterol by raising LDL receptors,” New England Journal of Medicine, vol. 305, no. 9, pp. 515–517, 1981. View at Google Scholar · View at Scopus
  39. R. Hampton, D. Dimster-Denk, and J. Rine, “The biology of HMG-CoA reductase: the pros of contra-regulation,” Trends in Biochemical Sciences, vol. 21, no. 4, pp. 140–145, 1996. View at Publisher · View at Google Scholar